|
Volumn 202, Issue , 2016, Pages 273-274
|
Effects of ezetimibe/simvastatin combination on metabolic parameters
|
Author keywords
Cholesterol; Ezetimibe; Inflammation; Insulin resistance; Simvastatin; Statin
|
Indexed keywords
BIOLOGICAL MARKER;
C REACTIVE PROTEIN;
EZETIMIBE;
EZETIMIBE PLUS SIMVASTATIN;
GLUCOSE;
GLYCOSYLATED HEMOGLOBIN;
INTERLEUKIN 1BETA;
INTERLEUKIN 6;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PHOSPHOLIPASE A2;
PROSTAGLANDIN F2 ALPHA;
SIMVASTATIN;
TOLL LIKE RECEPTOR 2;
TOLL LIKE RECEPTOR 4;
ANTILIPEMIC AGENT;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
HYPOCHOLESTEROLEMIC AGENT;
CARBOHYDRATE METABOLISM;
CHOLESTEROL BLOOD LEVEL;
COMBINATION CHEMOTHERAPY;
CYTOKINE PRODUCTION;
DRUG EFFECT;
DRUG EFFICACY;
ENZYME ACTIVITY;
GLUCOSE BLOOD LEVEL;
HEMOGLOBIN BLOOD LEVEL;
HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE;
HUMAN;
HYPERCHOLESTEROLEMIA;
LETTER;
METABOLIC PARAMETERS;
MONOTHERAPY;
OUTCOME ASSESSMENT;
PARTICLE SIZE;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
PROTEIN EXPRESSION;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
ANIMAL;
BLOOD;
FEMALE;
MALE;
ANIMALS;
ANTICHOLESTEREMIC AGENTS;
EZETIMIBE;
FEMALE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERCHOLESTEROLEMIA;
HYPOLIPIDEMIC AGENTS;
MALE;
SIMVASTATIN;
|
EID: 84960082892
PISSN: 01675273
EISSN: 18741754
Source Type: Journal
DOI: 10.1016/j.ijcard.2015.08.130 Document Type: Article |
Times cited : (6)
|
References (6)
|